On August 17, China's leading needle-free injector medical device technology company: BJKS Medical Technology Group released the "Quick Shuer" needle-free syringe for children with independent intellectual property rights. This product was approved for use in insulin, growth hormone and other fields Injection. Up to now, BJKS needle-free injection series products have achieved coverage of injection therapy patients of all ages.
Needle-free syringe is a brand-new way of drug delivery. It does not require a needle to penetrate into the skin. It relies on the principle of jet flow to eject the liquid medicine instantly through the micro-holes,directly apply the liquid medicine to penetrate the skin and reach the subcutaneous.
In China, there are about 7 million children suffering from short stature who need daily growth hormone injections. The age range is about 4 to 15 years. The recommended treatment cycle is generally about 18 months. The injection frequency is mostly once a day. The total injection The number is about 550 times. Children who need insulin injections are mostly due to type 1 diabetes, with an annual incidence of about one in 100,000, less often type 2 or other types of diabetes. The patient population is about 1 million, and the daily injections are mostly 4 times or more. Many, and need to be like this for a lifetime.
"Many children's long-term injection treatment plan depends on the parents rather than the doctor. When the child cries, the parent's judgment will linger between perceptual and rational. Some children will give up treatment after insisting on it for a period of time." Gong Chunxiu, director of the Department of Endocrinology, Beijing Children's Hospital Taking the treatment of short stature as an example, it is pointed out that the poor compliance of existing growth hormone therapy will directly affect the efficacy. This is mainly due to the high frequency of injections, long treatment time, and the fear, pain, and broken needles caused by traditional injection methods. Influence. The application of needle-free syringes can reduce the psychological impact of children during the treatment process, and further improve the compliance of injection treatment.
About BJKS
BJKS focus on the research and development, production and sales of needle-free injector in various fields.
It is a high-tech enterprise specialized in the R&D, manufacturing and sales of needle-free injector in various fields with 100,000-degree sterile production workshops and 10,000-degree sterile laboratory.
The company produce 180,000 injectors and 18 million pieces of consumables annually. Besides R&D ability, It also pays great attention to product design and has won the Germany Reddot Design Awards, Japan Good Design Award and China Red Star Awards. It has applied for 23 patents , including the international invention patent. Many clinical trials were completed, proving good medication absorption brought by needle-free injector.